FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W51987875> ?p ?o ?g. }

• W51987875 endingPage "91" @default.
• W51987875 startingPage "187" @default.
• W51987875 abstract "The Frey's syndrome, manifest after parotid trauma, is characterized by head and neck hyperemia and abundant sweating of the hyperemic skin in response to gustatory stimuli. The use of the botulin toxin to treat the symptoms in patients with Frey's syndrome has been described in numerous studies. For some time up until now our Center has achieved excellent results using the group A botulin toxin to overcome the hypertonus of the cricopharyngeal muscle in patients who had undergone laryngectomy and were rehabilitated with voice button. We have sought to extend the use of this toxin to Frey's syndrome, a relatively frequent complication of parotidectomy. A total of 86 patients participated in the study: 41 males (47.6%) and 45 females (52.4%) ranging in age from 25 to 77 years (average age 51 years). Of these patients 7 (8.1%) had undergone post-operative radiotherapy. Of the 86 patients studied, 18 referred significant symptoms in terms of abundance and frequency. The syndrome was considered severe if the symptoms were present at each meal and if the patient indicated a significant worsening of his quality of life. Intermittent episodes were indicated by 22 patients. The remaining 46 (43.5%) did not complain of any symptoms. The exact extension of the cervicofacial gustatory sweating was evaluated using the Minor test and the involved region was divided into 1 square centimeters sections. The amount of skin surface involved ranged from 10 to 80 square centimeters. The type A neurotoxin was frozen and was reconstituted with a sterile saline solution at a final concentration of 2.5 UI/0.1 ml. The intracutaneous infiltration was performed without anesthesia, infiltrating 0.1 ml of solution, containing 2.5 UI of toxin into the center of each 1 square centimeters section. Statistical analysis was performed to evaluate the potential relationship between how long the treatment was effective, incidence of recurrence, seriousness of the crises and the following variables: age, sex, histology, cutaneous surface involved, injected dose of botulin toxin and post-operative radiotherapy. In the group of 18 patients with severe symptoms (20.9%) the benefit was immediate in all cases although the recurrence rate was 50%. The Frey's syndrome symptoms disappeared within 7 days of infiltration. In the group of 22 patients with less severe involvement (25.5%), the treatment gave positive, definitive results in 16 patients (72.7%). Those patients whose symptoms persisted were treated a second time with an infiltration of 2.5 UI per square centimeters. We feel that the use of the type A botulin toxin is the most appropriate treatment for the Frey's syndrome. In fact, such treatment offers the following advantages: it is effective within 7 days, has limited side effects, can be applied on an outpatient basis, is inexpensive and is positively considered by the patients." @default.
• W51987875 created "2016-06-24" @default.
• W51987875 creator A5006768840 @default.
• W51987875 creator A5034886041 @default.
• W51987875 creator A5065382094 @default.
• W51987875 creator A5066850463 @default.
• W51987875 creator A5069493835 @default.
• W51987875 creator A5072736757 @default.
• W51987875 creator A5073885834 @default.
• W51987875 creator A5074785116 @default.
• W51987875 date "2000-06-01" @default.
• W51987875 modified "2023-09-25" @default.
• W51987875 title "[Post-parotidectomy Frey's syndrome. Treatment with botulinum toxin type A]." @default.
• W51987875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11139877" @default.
• W51987875 hasPublicationYear "2000" @default.
• W51987875 type Work @default.
• W51987875 sameAs 51987875 @default.
• W51987875 citedByCount "1" @default.
• W51987875 crossrefType "journal-article" @default.
• W51987875 hasAuthorship W51987875A5006768840 @default.
• W51987875 hasAuthorship W51987875A5034886041 @default.
• W51987875 hasAuthorship W51987875A5065382094 @default.
• W51987875 hasAuthorship W51987875A5066850463 @default.
• W51987875 hasAuthorship W51987875A5069493835 @default.
• W51987875 hasAuthorship W51987875A5072736757 @default.
• W51987875 hasAuthorship W51987875A5073885834 @default.
• W51987875 hasAuthorship W51987875A5074785116 @default.
• W51987875 hasConcept C141071460 @default.
• W51987875 hasConcept C2777478456 @default.
• W51987875 hasConcept C2778710640 @default.
• W51987875 hasConcept C2778817116 @default.
• W51987875 hasConcept C2778987478 @default.
• W51987875 hasConcept C2779186577 @default.
• W51987875 hasConcept C2779302907 @default.
• W51987875 hasConcept C2780474809 @default.
• W51987875 hasConcept C2781157581 @default.
• W51987875 hasConcept C42219234 @default.
• W51987875 hasConcept C54355233 @default.
• W51987875 hasConcept C71924100 @default.
• W51987875 hasConcept C81182388 @default.
• W51987875 hasConcept C86803240 @default.
• W51987875 hasConceptScore W51987875C141071460 @default.
• W51987875 hasConceptScore W51987875C2777478456 @default.
• W51987875 hasConceptScore W51987875C2778710640 @default.
• W51987875 hasConceptScore W51987875C2778817116 @default.
• W51987875 hasConceptScore W51987875C2778987478 @default.
• W51987875 hasConceptScore W51987875C2779186577 @default.
• W51987875 hasConceptScore W51987875C2779302907 @default.
• W51987875 hasConceptScore W51987875C2780474809 @default.
• W51987875 hasConceptScore W51987875C2781157581 @default.
• W51987875 hasConceptScore W51987875C42219234 @default.
• W51987875 hasConceptScore W51987875C54355233 @default.
• W51987875 hasConceptScore W51987875C71924100 @default.
• W51987875 hasConceptScore W51987875C81182388 @default.
• W51987875 hasConceptScore W51987875C86803240 @default.
• W51987875 hasIssue "3" @default.
• W51987875 hasLocation W519878751 @default.
• W51987875 hasOpenAccess W51987875 @default.
• W51987875 hasPrimaryLocation W519878751 @default.
• W51987875 hasRelatedWork W117776086 @default.
• W51987875 hasRelatedWork W2006862541 @default.
• W51987875 hasRelatedWork W2105370257 @default.
• W51987875 hasRelatedWork W2315709972 @default.
• W51987875 hasRelatedWork W2335365458 @default.
• W51987875 hasRelatedWork W2474039552 @default.
• W51987875 hasRelatedWork W2834885362 @default.
• W51987875 hasRelatedWork W2945124548 @default.
• W51987875 hasRelatedWork W51987875 @default.
• W51987875 hasRelatedWork W64874741 @default.
• W51987875 hasVolume "20" @default.
• W51987875 isParatext "false" @default.
• W51987875 isRetracted "false" @default.
• W51987875 magId "51987875" @default.
• W51987875 workType "article" @default.